Powder: -20°C for 3 years
In solvent: -80°C for 2 years
SMAP-2 is an orally bioavailable activator of <a href="/target/Phosphatase" style="display: inline; color: #c13a36">Phosphatase</a> 2A (PP2A) which binds to the PP2A Aα scaffold subunit to drive conformational changes in PP2A. It inhibits the growth of KRAS-mutant lung cancers .
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 8-10 weeks | $ 970.00 | |
50 mg | 8-10 weeks | $ 1,980.00 | |
100 mg | 8-10 weeks | $ 2,500.00 |
Description | SMAP-2 is an orally bioavailable activator of phosphatase 2A (PP2A) which binds to the PP2A Aα scaffold subunit to drive conformational changes in PP2A. It inhibits the growth of KRAS-mutant lung cancers . |
Synonyms | DT-1154 |
Molecular Weight | 532.57 |
Formula | C27H27F3N2O4S |
CAS No. | 1809068-70-9 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SMAP-2 1809068-70-9 Metabolism Phosphatase DT-1154 SMAP2 SMAP 2 Inhibitor inhibitor inhibit